Risk stratification for the prediction of overall survival could assist treatment decision-making at diagnosis of castration-resistant prostate cancer: a multicentre collaborative study in Japan.
Taizo UchimotoKazumasa KomuraWataru FukuokayaTakahiro KimuraKazuhiro TakahashiYuya FujiwaraTomohisa MatsunagaTakeshi TsutsumiTakuya TsujinoRyoichi MaenosonoYuki YoshikawaKohei TaniguchiTomohito TanakaHirofumi UeharaNaokazu IbukiHajime HiranoHayahito NomiKiyoshi TakaharaTeruo InamotoShin EgawaHaruhito AzumaPublished in: BJU international (2020)
The new risk group stratification system could predict patient survival at the diagnosis of mCRPC. Given the convenience of these risk definitions, physicians may be encouraged to consider these risk groups in daily practice.